Account
Havas Media bags offline media mandate for Hamdard’s food division
New Delhi: Havas Media India has won the offline media mandate for Hamdard Laboratories’ food division, which includes the widely known beverage brand RoohAfza and all its extensions, Hamdard honey, Hamdard saffron, oils, healthy teas, snacks, dairy products, and other value added innovative food products.
The account will be handled out of the agency’s Gurgaon office, led by Havas Media, president-north and west, Uday Mohan.
Established in 1906 by Hakeem Hafiz Abdul Majeed, Hamdard Laboratories (India) is a leading manufacturer and marketer of herbal products and medicines that combine Unani methodology with progressive research. Hamdard’s food division offers a portfolio of products including juices, squashes, fusion drinks, milkshakes, spices, and honey. RoohAfza is Hamdard’s flagship product under the beverage category.
Hamdard Laboratories India (Foods Division), CEO, Hamid Ahmed said, “We aim to become a truly home-friendly food & beverage brand with a core purpose of offering health through foods. We are confident of Havas Media’s capabilities and strongly believe in their Meaningful Brands philosophy, making them the right partner for us. We look forward to this partnership.”
Havas Media Group India, CEO, Mohit Joshi said, “Hamdard is a legacy brand, a trusted household name with a presence of over 100 years, offering natural and healthy products. With health and immunity taking centre stage in our lives, herbal and ayurvedic food products and supplements are becoming the preferred choice of consumers. Our Meaningful Brands’ philosophy resonates well with a brand like Hamdard and we are glad to be appointed as their media partner. We look forward to our association in driving the brand’s meaningful journey.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








